Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,570 | 39,878 | 45,277 | 27,349 | 22,063 |
| Marketable Securities | 89,024 | 79,228 | 172,294 | 164,065 | 32,068 |
| Receivables | 318 | 298 | 484 | 623 | 772 |
| TOTAL | $125,951 | $128,856 | $231,550 | $205,032 | $57,493 |
| Non-Current Assets | |||||
| PPE Net | 1,008 | 1,620 | 1,099 | 1,335 | 1,654 |
| Investments And Advances | 90,302 | 62,771 | 12,242 | 34,242 | 0 |
| Intangibles | 0 | 0 | 6,973 | 7,048 | 7,123 |
| Other Non-Current Assets | 3,066 | 4,158 | 2,732 | 3,554 | 4,514 |
| TOTAL | $94,376 | $68,549 | $23,046 | $46,179 | $13,291 |
| Total Assets | $220,327 | $197,405 | $254,596 | $251,211 | $70,784 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,690 | 8,878 | 10,351 | 9,985 | 5,254 |
| Accrued Expenses | 20,333 | 19,446 | 8,701 | 10,051 | 5,906 |
| Other current liabilities | 2,683 | 2,628 | N/A | N/A | N/A |
| TOTAL | $31,596 | $30,952 | $21,938 | $22,931 | $14,874 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 10,653 |
| Deferred Revenues | 3,890 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 13,139 | 9,274 | 34,670 | 30,572 | 7,240 |
| TOTAL | $33,177 | $9,274 | $35,037 | $30,939 | $18,260 |
| Total Liabilities | $64,773 | $40,226 | $56,975 | $53,870 | $33,134 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 107,919 | 70,925 | 66,693 | 61,275 | 51,804 |
| Common Shares | 1 | 1 | 1 | N/A | N/A |
| Retained earnings | -902,861 | -770,796 | -682,315 | -595,407 | -504,542 |
| Other shareholders' equity | 97 | -106 | -897 | -223 | -94 |
| TOTAL | $155,554 | $157,179 | $197,621 | $197,341 | $37,650 |
| Total Liabilities And Equity | $220,327 | $197,405 | $254,596 | $251,211 | $70,784 |